Abstract
Focused SAR studies were carried out around 5-heteroaryl and 1-amide portions of the 2-chlorobenzamide scaffold, resulting in the discovery of a potent, metabolically stable and centrally penetrable antagonist against P2X(7) receptor.
Copyright 2010 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
Anti-Inflammatory Agents / chemical synthesis
-
Anti-Inflammatory Agents / chemistry*
-
Anti-Inflammatory Agents / pharmacokinetics
-
Benzamides / chemical synthesis
-
Benzamides / chemistry*
-
Benzamides / pharmacokinetics
-
Central Nervous System / drug effects
-
Drug Discovery
-
Humans
-
Male
-
Microsomes, Liver / metabolism
-
Purinergic P2 Receptor Antagonists*
-
Pyrimidines / chemical synthesis
-
Pyrimidines / chemistry*
-
Pyrimidines / pharmacokinetics
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, Purinergic P2 / metabolism
-
Receptors, Purinergic P2X7
-
Structure-Activity Relationship
Substances
-
Anti-Inflammatory Agents
-
Benzamides
-
P2RX7 protein, human
-
Purinergic P2 Receptor Antagonists
-
Pyrimidines
-
Receptors, Purinergic P2
-
Receptors, Purinergic P2X7